November 25, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and ...

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable ...

Earlier this summer, I concluded to keep an eye on shares of STAAR Surgical (NASDAQ:STAA). The manufacturer of the so-called EVO ICL Lens, a clear vision solution for nearsightedness which does ...

STAAR Surgical has a 52 week low of $25.88 and a 52 week high of $52.68. The company has a market cap of $1.43 billion, a PE ratio of 66.14 and a beta of 0.61. STAAR Surgical Profile ...

Canaccord analyst William Plovanic lowered the firm’s price target on Staar Surgical (STAA) to $28 from $31 and keeps a Hold rating on the shares. Canaccord said they are bullish on the Med-Tech ...

Morgan Stanley analyst Patrick Wood lowered the firm’s price target on Staar Surgical (STAA) to $23 from $27 and keeps an Underweight rating on the shares. While stating that the “company is ...

Bridgewater Associates LP reduced its position in STAAR Surgical (NASDAQ:STAA – Free Report) by 51.6% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned ...